Your browser is no longer supported. Please, upgrade your browser.
IBB iShares Nasdaq Biotechnology ETF weekly Stock Chart
IBB [NASD]
iShares Nasdaq Biotechnology ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.30%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.46%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-3.56%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-2.42%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-10.29%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range89.01 - 122.97 Perf YTD9.46%
Dividend0.12 P/FCF- EPS past 5Y- ROI- 52W High-14.17% Beta-
Dividend %0.11% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low18.58% ATR1.72
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)56.55 Volatility1.41% 1.72%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.09 Prev Close104.63
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.40M Price105.55
Recom- SMA202.14% SMA501.08% SMA200-0.78% Volume2,630,021 Change0.88%
Sep-20-19 11:04AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Sep-18-19 01:01PM  Sell on the Pop Prospects: September 18 Edition ETF Database
Aug-29-19 07:39AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-27-19 10:05AM  Amgen to Buy Celgene's Otezla: 5 ETF Drugs Zacks
Aug-20-19 01:06PM  8 Biotech Stocks to Watch After the Q2 Earnings Season InvestorPlace
Aug-07-19 06:45AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-06-19 04:22PM  Biotech ETFs in Focus on Impressive Q2 Earnings Results Zacks
Aug-03-19 10:18AM  The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts Benzinga
Jul-26-19 12:04PM  4 Biotech Stocks Sliding Lower InvestorPlace
Jul-16-19 07:01AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jul-15-19 08:45AM  Capicor Therapeutics' stock rockets on heavy volume after positive MD trial results MarketWatch
Jul-09-19 05:10PM  Biotech ETFs Strengthen After Judge Blocks Trumps Drug Pricing Rule ETF Trends
04:18PM  Drug Pricing War: Pharma, Biotech Stocks Score A Win Over Trump Investor's Business Daily
07:15AM  Altimmune's stock soars after adding NASH candidate with purchase of Spitfire Pharma MarketWatch
Jul-05-19 09:46AM  Tyme Technologies stock soars on heavy volume after upbeat update to cancer treatment study MarketWatch
Jul-03-19 08:21AM  Unum Therapeutics stock plunges toward record low after FDA places 'clinical hold' on trial MarketWatch
Jul-02-19 07:42AM  Incyte enters license pact with Zai Lab to commercialize its cancer treatment in Greater China MarketWatch
Jun-26-19 09:31AM  Adaptive Biotechnologies to sell more shares in IPO, as expected pricing increases MarketWatch
Jun-25-19 09:33AM  Despite Recent Volatility, Biotech Stocks Look Poised to Pop Investopedia
09:24AM  The Rush to Biotech ETFs Is Back On (IBB, XBI) Investopedia
Jun-21-19 09:15AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
07:31AM  ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH MarketWatch
Jun-17-19 01:31PM  Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million MarketWatch
01:17PM  Karuna Therapeutics sets IPO terms, to be valued at up to $363 million MarketWatch
Jun-14-19 09:50AM  Morphic Holding sets terms of IPO to raise up to $80 million MarketWatch
07:48AM  Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal MarketWatch
Jun-13-19 07:27AM  Provention Bio's stock surges after calling off public stock offering MarketWatch
Jun-12-19 06:29AM  Barclays Has New Plays for Healthcare Fans SmarterAnalyst
Jun-07-19 08:56AM  Cancer genomics company Personalis expects to raise up to $107 million in IPO MarketWatch
07:48AM  Stoke Therapeutics to raise up to $107 million in IPO MarketWatch
Jun-04-19 11:07AM  Biotech Sector Could Enter Bear Market Investopedia
May-30-19 06:53AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
May-23-19 01:21PM  Ideaya Biosciences' stock opened 40% above its IPO price, then pared most of its gains MarketWatch
May-20-19 09:02AM  Outlook Therapeutics stock rockets on heavy volume again, set to triple in 3 days MarketWatch
May-17-19 09:47AM  Outlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 days MarketWatch
May-15-19 06:55AM  Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now SmarterAnalyst
May-13-19 10:54PM  Reaping the Benefits of In-Depth Knowledge of ETFs Insider Monkey
02:15PM  FDA Issues Final Guidelines To Make Interchangeable Biosimilars More Easily Available Benzinga
May-09-19 07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-07-19 04:57PM  Biotech ETFs in Focus on String of Q1 Earnings Beats Zacks
May-02-19 01:21PM  These 6 biotech stocks are promising takeover targets MarketWatch
Apr-30-19 01:00PM  Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Benzinga
10:39AM  Axcella Health sets IPO terms, which could value the biotech at up to $505.7 million MarketWatch
Apr-26-19 02:01PM  Gilead Stock Is Due for a Comeback, Analyst Says Barrons.com
Apr-25-19 01:26PM  Can Health Care Recover from Medicare for All? Harvest Exchange
Apr-24-19 04:04PM  Will Biotech ETFs Continue to Rally in Q1 Earnings? Zacks
Apr-19-19 09:27AM  Health-care drama has now spread to biopharma stocks MarketWatch
Apr-18-19 12:17PM  Intuitive Surgical Stock Is Down but Not Out InvestorPlace
07:00AM  Mustang Bio's stock soars to near 4-fold gain after deal to commercialize 'bubble boy' disease treatment MarketWatch
Apr-15-19 01:49PM  ImmunoGen Stock Is in Trouble Going Into Earnings InvestorPlace
10:46AM  Bio-Path's stock rockets after withdrawal of stock offering MarketWatch
Apr-12-19 08:16AM  Biotech company Axcella Health files for IPO MarketWatch
07:23AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Apr-10-19 04:44PM  Global X Launches GNOM ETF to Tap Booming Genomics Space Zacks
11:11AM  Is AstraZeneca Stock Worth Buying Before Earnings? InvestorPlace
Apr-08-19 03:09PM  Concert Pharmaceuticals' stock takes a sharp dive after disappointing patent appeal board ruling MarketWatch
Apr-03-19 12:23PM  Democrats, Republicans agree on legislation targeting drug prices MarketWatch
07:44AM  Advaxis' stock plummets after public offering prices at deep discount MarketWatch
Apr-02-19 09:00AM  ADMA Biologics' stock rockets on heavy volume after FDA approval of immunodeficiency treatment MarketWatch
Mar-26-19 07:51AM  Alderya Therapeutics stock soars after conjunctivitis treatment trial meets key endpoints MarketWatch
Mar-25-19 09:26AM  Curis' stock rockets on heavy volume after $135.7 million deal to sell portion of Erivedge royalties MarketWatch
08:49AM  5 biotech stocks that could be the next big winners MarketWatch
07:26AM  Biogen sets new $5 billion stock repurchase program in aftermath of stock plunge MarketWatch
Mar-21-19 11:16AM  Biotech Funds Could Generate Profitable Short Sales Investopedia
09:46AM  Biogen shares tank nearly 30% after pulling key Alzheimers drug trial Yahoo Finance
06:52AM  Novocure Chief Science Officer Eilon Kirson to retire after 7 years in the role MarketWatch
Mar-20-19 07:07AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Mar-18-19 03:05PM  Aerpio Pharmaceuticals stock plummets after failed trial of diabetic retinopathy treatment MarketWatch
01:12PM  Dare Bioscience stock rockets to pace all gainers after positive findings from VVA treatment study MarketWatch
07:29AM  PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent MarketWatch
Mar-14-19 03:51PM  Gilead Stock Could Surge to $84, Says Analyst Barrons.com
Mar-13-19 10:35AM  Akari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meeting MarketWatch
Mar-11-19 12:27PM  Is iShares Nasdaq Biotechnology Index Fund a Buy? Motley Fool
Mar-10-19 02:32PM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs Benzinga
Mar-05-19 03:32PM  Biotech stocks turn lower after reports of FDA commissioner resigning MarketWatch
08:00AM  CNBC ETF Edge: Biotech Getting Sick? ETF.com
Mar-04-19 01:44PM  How you should trade the biotech ETFs CNBC Videos
08:39AM  Nightstar Therapeutics' stock rockets on Biogen buyout deal valued at $877 million MarketWatch
Mar-01-19 06:51AM  Immunogen's stock loses nearly half its value after trial of cancer treatment fails to meet primary endpoint MarketWatch
Feb-27-19 03:00PM  7 of the Best Biotech ETFs InvestorPlace
Feb-25-19 05:54PM  Technician says it's time to fade the biotech rally CNBC Videos
Feb-20-19 09:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Feb-14-19 01:00PM  Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings Zacks
Feb-12-19 03:21PM  Anchiano Therapeutics' stock set to close well below its IPO price MarketWatch
09:29AM  Anchiano Therapeutics IPO prices below assumed price MarketWatch
Feb-07-19 10:49AM  Alector's stock opens below IPO price, then swings above it MarketWatch
Jan-29-19 08:56AM  Biogen Stock Running in Place Despite Strong Quarter Investopedia
Jan-28-19 08:52AM  Amgen downgraded to in-line from outperform by Evercore ISI MarketWatch
Jan-25-19 01:36PM  MacroGenics stock gains 4% after FDA lifts partial clinical hold MarketWatch
10:02AM  Intuitive Surgical Stock Dips Are Buying Opportunities InvestorPlace
08:32AM  NuCana's stock soars after withdrawing ADS offering, which triggered a big selloff MarketWatch
Jan-24-19 01:00PM  What's Behind the Biotech ETF Rally to Start 2019? Zacks
Jan-23-19 07:51AM  Rigel Pharmaceuticals stock up 9% after announcing licensing agreement with Grifols MarketWatch
Jan-22-19 11:06AM  Editas stock down 21% after announcing CEO departure MarketWatch
09:17AM  Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data MarketWatch
Jan-17-19 09:10AM  Lipocine's stock rockets on premarket leading volume after upbeat liver fat study results MarketWatch
07:13AM  Trade of the Day: The Biotechnology Stocks ETF Is Running Out of Steam InvestorPlace
Jan-16-19 09:19AM  Aptinyx stock falls 67% after phase 2 trial fails to meet primary endpoint MarketWatch
Jan-14-19 06:00PM  Democrats target drug prices CNBC Videos
Jan-11-19 10:59AM  Why Sarepta Therapeutics Stock Is Starting to Shine Again InvestorPlace
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.